Merz Pharmaceuticals Gmbh

FRANKFURT AM MAIN, Germany, October 21, 2011 - At the 5thInternational Dystonia Symposium (IDS)in Barcelona, Spain (20-22 October 2011),Merz Pharmaceuticalspresented important clinical data concerning the long-term, sustained efficacy and safety ofXEOMINfor the treatment of patients with dystonia.